🔴 OMO-103, a drug developed by @peptomyc, will be tested as a therapy for patients with advanced osteosarcoma. 

The trial is funded by the @OSInstitute and aims to evaluate the clinical activity, safety and pharmacodynamics ➡️ https://linke.to/OSTEOMYCVHIO

#OSTEOMYC